We took a chat with the BioInnovation Institute about our mission and vision, key drivers for Commit Biologics and the transition from an academic mindset to a more commercial mindset.
Read more at BioInnovation Institue
More news
January 8 – 2025
Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform Brings decades of experience in developing strong pipelines of …
August 28 – 2023
Krishna Polu is appointed CEO of Commit Biologics. Krishna brings a wealth of operating experience to the team with a track record of pipeline advancement and drug approvals across multiple therapeutics areas. Most recently, …
June 28 – 2023
A joint collaboration between researchers from Commit Biologics, Christian-Albrechts-University in Kiel and Aarhus University has led to a better understanding of the complement system. The complement system plays a vital role in immune defenses. …
For inquiries please contact us
at info@commitbio.com
Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark
© 2025 Commit Biologics. All rights reserved.
